Detalhe da pesquisa
1.
Preexisting and treatment-emergent autoimmune cytopenias in patients with CLL treated with targeted drugs.
Blood
; 137(25): 3507-3517, 2021 06 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-33651883
2.
Reply to "successful early use of anti-SARS-CoV-2 monoclonal neutralizing antibodies in SARS-CoV-2 infected hematological patients-A Czech multicenter experience": A case series of SARS-CoV-2 Omicron infection and aggressive lymphoma in the Sotrovimab era.
Hematol Oncol
; 41(1): 213-217, 2023 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-36156809
3.
Predictors of ibrutinib-associated atrial fibrillation: 5-year follow-up of a prospective study.
Hematol Oncol
; 41(3): 363-370, 2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-36762406
4.
Acquired hemophilia A and delta storage pool deficiency in a patient with indolent non-Hodgkin lymphoma.
Platelets
; 33(1): 168-170, 2022 Jan 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33426985
5.
Comparison of ibrutinib and idelalisib plus rituximab in real-life relapsed/resistant chronic lymphocytic leukemia cases.
Eur J Haematol
; 106(4): 493-499, 2021 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-33378569
6.
CD34-Positive Blast Count and p53 Expression in Bone Marrow Biopsies of Patients with Low-Risk Myelodysplastic Syndromes: Potential Predictive Tools of Response to Erythropoietin Stimulating Agents.
Pathobiology
; 88(3): 242-250, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33588425
7.
Effect of ibrutinib treatment on hemolytic anemia and acrocyanosis in cold agglutinin disease/cold agglutinin syndrome.
Blood
; 138(20): 2002-2005, 2021 11 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-34293088
8.
Risk of hepatitis B virus reactivation in chronic lymphocytic leukemia patients receiving ibrutinib with or without antiviral prophylaxis. A retrospective multicentric GIMEMA study.
Haematologica
; 107(6): 1470-1473, 2022 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35199505
9.
Biological and molecular characterization of a rare case of cutaneous Richter syndrome.
Hematol Oncol
; 35(4): 869-874, 2017 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-27400669
10.
Increase of immunoglobulin A during ibrutinib therapy reduces infection rate in chronic lymphocytic leukemia patients.
Hematol Oncol
; 39(1): 141-144, 2021 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-33034902
11.
Assessment of the 4-factor score: Retrospective analysis of 586 CLL patients receiving ibrutinib. A campus CLL study.
Am J Hematol
; 96(5): E168-E171, 2021 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33580969
12.
Effectiveness of ibrutinib as first-line therapy for chronic lymphocytic leukemia patients and indirect comparison with rituximab-bendamustine: Results of study on 486 cases outside clinical trials.
Am J Hematol
; 96(8): E269-E272, 2021 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33878220
13.
Low-dose alemtuzumab in refractory/relapsed chronic lymphocytic leukemia: Genetic profile and long-term outcome from a single center experience.
Am J Hematol
; 90(11): 970-4, 2015 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-26201283
14.
Venetoclax penetrates in cerebrospinal fluid and may be effective in chronic lymphocytic leukemia with central nervous system involvement.
Haematologica
; 104(5): e222-e223, 2019 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30765472
15.
Decitabine treatment for an unusual case of atypical chronic myeloid leukemia (aCML) with a concomitant chronic lymphocytic leukemia (CLL).
Hematol Oncol
; 37(4): 505-507, 2019 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-31102420
16.
A scoring system to predict the risk of atrial fibrillation in chronic lymphocytic leukemia.
Hematol Oncol
; 37(4): 508-512, 2019 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-31335982
17.
Real-World Outcome of Treatment with Single-Agent Ibrutinib in Italian Patients with Chronic Lymphocytic Leukemia: Final Results of the EVIdeNCE Study.
Cancers (Basel)
; 16(6)2024 Mar 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-38539561
18.
Idelalisib rapidly improves platelet function tests in patients with chronic lymphocytic leukaemia.
Br J Haematol
; 183(5): 825-828, 2018 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-29315493
19.
Should treatment of hypogammaglobulinemia with immunoglobulin replacement therapy (IgRT) become standard of care in patients with chronic lymphocytic leukemia?
Front Immunol
; 14: 1062376, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37122737
20.
Preliminary Evidence of Good Safety Profile and Outcomes of Early Treatment with Tixagevimab/Cilgavimab Compared to Previously Employed Monoclonal Antibodies for COVID-19 in Immunocompromised Patients.
Biomedicines
; 11(6)2023 May 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-37371635